-
In a British study telling the patient their lung age after spirometry doubled the likelihood of their stopping smoking at one year.
-
Middle-aged women who followed the DASH diet had a lower risk of stroke and coronary heart disease over a 24-year-period than comparable women who did not.
-
Among veterans with risk factors for hepatitis C, a screening program yields results of limited value. The number needed to screen to yield a treatable case of hepatitis C was 451, but the number needed to screen for a successful outcome was more than 4000.
-
Coronary artery disease (CAD) is the most common cause of death in America, and diabetics suffer a disproportionate burden of risk from cardiovascular disease.
-
12-lead ECG and lead II rhythm strip obtained from a 72-year-old man with hypertension, ESRD, and heart failure. Which one lead is of most concern to you?
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Clinicians are becoming more attuned to the many complications of influenza, particularly with the high morbidity and mortality seen with H5N1 strains spreading around the world.
-
In This Issue: FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Eight hiv-infected patients (mean CD4+ t cell count 622 cells/uL) who had been receiving effective HAART for an average of 8.4 years were included in this study. PBMCs were obtained by leukapheresis and endoscopic terminal ileum biopsies were performed to obtain samples of Gut-Associated Lymphoid Tissue (GALT).
-
In 1985, the newly fda-approved antimicrobial agent, Primaxin® (imipenem/cilastatin), introduced a new class of drugs known as carbapenems. This new class provided benefits as well as unwanted side effects. Carbapenems work similarly to other â-lactam antibiotics, but with substantially broader-spectrum of activity and better penetration into bacterial cell walls to prevent synthesis.
